Additional Effects of Faricimab in Aflibercept Low-Responders: Retinal Morphology and Function in Eyes with Neovascular Age Related Macular Degeneration Following a Switch Between Two Anti-VEGF Agents. [PDF]
Clin OphthalmolRothbächer J +3 more
europepmc +1 more source
Scutellarin attenuates hypoxia-induced retinal neovascularization through bidirectional modulation of the VEGF/Ang/Tie2 pathway. [PDF]
Front PharmacolDing S +5 more
europepmc +1 more source
Effect of Faricimab on Visual Acuity and Retinal Structure in Neovascular Age-Related Macular Degeneration Previously Treated With Anti-VEGF Therapy. [PDF]
J Vitreoretin DisSattah N +10 more
europepmc +1 more source
Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs. [PDF]
Clin OphthalmolLytvynchuk L +5 more
europepmc +1 more source
Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes. [PDF]
J Clin MedEsteban-Floría O +9 more
europepmc +1 more source
Sterile Intraocular Inflammation in Patients Receiving Both Faricimab and High-Dose Aflibercept in Consecutive Order. [PDF]
J Vitreoretin DisDwomoh EA, Prasad A, Nanda T.
europepmc +1 more source
Intravitreal Faricimab for the Management of Bilateral Macular Neovascularization Secondary to Macular Telangiectasia Type 2. [PDF]
CureusRao P, Rao A, Jaffer JM, John AS.
europepmc +1 more source
Intraocular Inflammation Following Intravitreal Faricimab: Insights from Five Bilateral Cases. [PDF]
J Vitreoretin DisDhillon N, Macleod S.
europepmc +1 more source
Central Retinal Artery Occlusion After Intravitreal Injection of Faricimab: A Case Report. [PDF]
CureusHirai H +4 more
europepmc +1 more source
The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: a real-world analysis. [PDF]
Graefes Arch Clin Exp OphthalmolBoscia G +10 more
europepmc +1 more source